바이오의약품 위탁생산 시장 규모, 점유율, 성장 분석(서비스별, 종류별, 운영 규모별, 원료별, 분자종류별, 지역별) : 산업 예측(2025-2032년)
Biopharmaceuticals Contract Manufacturing Market Size, Share, Growth Analysis, By Service (Manufacturing, Formulation & Fill-Finish), By Type, By Scale Of Operation, By Source, By Molecule Type, By Region - Industry Forecast 2025-2032
상품코드:1623938
리서치사:SkyQuest
발행일:2025년 01월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 바이오의약품 위탁생산 시장 규모는 2023년 165억 달러로 평가되며, 2024년 178억 5,000만 달러에서 2032년 335억 4,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 8.2%의 CAGR로 성장할 것으로 예상됩니다.
세계 바이오의약품 위탁생산 시장은 신약 개발에 필요한 투자 감소, 첨단 기술에 대한 접근성 강화, 혁신적 제품의 빠른 시장 진입 등을 배경으로 크게 성장할 것으로 전망됩니다. 특히 써모피셔 사이언티픽이 최근 1억 8,000만 달러를 투자해 플레인빌에 새로운 제조시설을 건설한 것은 이러한 추세를 상징적으로 보여주며, 이를 통해 급증하는 소비자 수요에 대응할 수 있는 생산능력을 강화할 수 있게 되었습니다. 또한, 바이오프로세스의 급속한 기술 발전은 고비용과 배치 전환 문제 등 기존의 제조 문제를 완화하고 전 세계 위탁 서비스 업체들의 역량을 향상시키고 있습니다. 또한 2021년 박스터 인터내셔널이 COVID-19 백신 생산을 위해 박스터 바이오파마 솔루션즈(Baxter Biopharma Solutions)와 파트너십을 맺은 것에서 알 수 있듯이, 주요 기업 간의 전략적 합병, 인수, 합작투자가 이러한 서비스에 대한 수요를 촉진하고 있습니다.
목차
소개
분석 목적
시장 범위
정의
분석 방법
정보 조달
2차·1차 데이터 방법
시장 규모 예측
시장 상정과 제약
주요 요약
시장 개요와 전망
수급 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porters 분석
시장의 주요 인사이트
주요 성공요인
경쟁 정도
주요 투자 기회
시장 생태계
시장 매력도 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
기술 분석
규제 분석
특허 분석
사례 연구
FDA 공인 바이오의약품 CMO 센터
세계의 바이오의약품 위탁생산 시장 규모·CAGR : 서비스별(2025-2032년)
시장 개요
제조업
배합·완제
포장·라벨
기타 서비스
세계의 바이오의약품 위탁생산 시장 규모·CAGR : 종류별(2025-2032년)
시장 개요
생물학적 제제 원료의약품 제조
생물학적 제제 제품 제조
세계의 바이오의약품 위탁생산 시장 규모·CAGR : 운영 규모별(2025-2032년)
시장 개요
상업 운영
임상 운영
세계의 바이오의약품 위탁생산 시장 규모·CAGR : 원료별(2025-2032년)
시장 개요
포유 세포 발현계
비포유 세포 발현계
세계의 바이오의약품 위탁생산 시장 규모·CAGR : 분자 종류별(2025-2032년)
시장 개요
단클론항체
세포 및 유전자 치료
항체약물접합체
백신
치료용 펩타이드와 단백질
기타 분자 유형
세계의 바이오의약품 위탁생산 시장 규모·CAGR : 치료 분야별(2025-2032년)
시장 개요
종양학
자가면역질환
대사성 질환
심혈관질환
신경학
감염증
기타 치료 분야
세계의 바이오의약품 위탁생산 시장 규모·CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 구도
상위 5개사의 비교
주요 기업의 시장 포지셔닝(2024년)
주요 기업이 채용한 전략
시장의 최근 동향
주요 기업의 시장 점유율(2024년)
주요 기업 개요
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
매출 전년비 비교(2022-2024년)
주요 기업 개요
Lonza(스위스)
Thermo Fisher Scientific Inc.(미국)
WuXi Biologics(중국)
Catalent, Inc.(미국)
Samsung Biologics(한국)
Boehringer Ingelheim International GmbH(독일)
Fujifilm Holdings Corporation(일본)
AbbVie Inc.(미국)
Eurofins Scientific(룩셈부르크)
GenScript Biotech Corporation(중국)
AGC Inc.(일본)
Merck
KGaA(독일)
JSR Corporation(일본)
Stelis(India)
Recipharm AB(스웨덴)
Emergent(미국)
Shanghai Fosun Pharmaceutical Co., Ltd.(중국)
Lotte Biologics(한국)
Hepalink Group(중국)
Curia Global, Inc.(미국)
결론과 추천사항
ksm
영문 목차
영문목차
Global Biopharmaceuticals Contract Manufacturing Market size was valued at USD 16.5 billion in 2023 and is poised to grow from USD 17.85 billion in 2024 to USD 33.54 billion by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).
The global biopharmaceuticals contract manufacturing market is poised for significant growth, driven by reduced investment needs for new drug development, enhanced access to advanced technologies, and expedited market entry for innovative products. Notably, Thermo Fisher Scientific's recent USD 180 million investment in a new manufacturing facility in Plainville exemplifies this trend, enabling increased production capacity to meet surging consumer demand. Additionally, rapid technological advancements in bioprocessing are alleviating traditional manufacturing challenges, such as high costs and batch changeover issues, boosting the capabilities of contract service providers worldwide. Furthermore, strategic mergers, acquisitions, and joint ventures among key market players are fueling demand for these services, as illustrated by Baxter International's collaboration with Baxter BioPharma Solutions for COVID-19 vaccine production in 2021.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biopharmaceuticals Contract Manufacturing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Biopharmaceuticals Contract Manufacturing Market Segmental Analysis
Global Biopharmaceuticals Contract Manufacturing Market is segmented by Service, Type, Scale Of Operation, Source, Molecule Type,TherapeuticArea and region. Based on Service, the market is segmented into Manufacturing, Formulation & Fill-Finish, Packaging & Labeling and Other Services. Based on Type, the market is segmented into Biologic Drug Substance Manufacturing and Biologic Drug Product Manufacturing. Based on Scale Of Operation, the market is segmented into Commercial Operations and Clinical Operations. Based on Source, the market is segmented into Mammalian Expression Systems and Non-Mammalian Expression Systems. Based on Molecule Type, the market is segmented into Monoclonal Antibodies, Cell & Gene Therapies, Antibody-Drug Conjugates, Vaccines, Therapeutic Peptides & Proteins and Other Molecule Types. Based on Therapeutic Area, the market is segmented into Oncology, Autoimmune Diseases, Metabolic Diseases, Cardiovascular Diseases, Neurology, Infectious Diseases and Other Therapeutic Areas. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Biopharmaceuticals Contract Manufacturing Market
The global biopharmaceuticals contract manufacturing market is primarily driven by the surging demand for biological therapies, which is influenced by several key factors. Notably, the continual rise in the demand for generics, coupled with heightened research and development efforts and investments in cutting-edge technologies, is expected to propel market growth during the forecast period. Additionally, the expansion of the nuclear medicine sector and a greater focus on specialty medicines are anticipated to further stimulate market progression. These elements collectively contribute to a promising landscape for the biopharmaceuticals contract manufacturing market in the years ahead.
Restraints in the Global Biopharmaceuticals Contract Manufacturing Market
The global biopharmaceuticals contract manufacturing market is facing several restraints that hinder its growth during the forecast period. Key challenges include labeling and packaging complications, along with sterilization issues that complicate the manufacturing process. Furthermore, a general lack of consumer trust combined with insufficient knowledge regarding the manufacturing processes may further restrict market expansion in the upcoming years. These various associated problems are critical factors that stakeholders need to address in order to facilitate smoother operations and enhance market performance in the highly competitive biopharmaceuticals landscape.
Market Trends of the Global Biopharmaceuticals Contract Manufacturing Market
The Global Biopharmaceuticals Contract Manufacturing market is witnessing a notable trend driven by technological advancements, particularly the integration of artificial intelligence (AI). In recent years, the surge in scientific exploration aimed at addressing critical health challenges has propelled market expansion. AI's burgeoning role in analyzing patient symptoms and facilitating real-time data tracking for disease patterns is revolutionizing manufacturing processes. This technological synergy not only enhances efficiency but also fosters innovation in drug development, leading to improved therapeutic solutions. As a result, stakeholders can anticipate robust growth opportunities in the biopharmaceutical contract manufacturing sector in the foreseeable future.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies
FDA Approved Biopharmaceuticals CMOs Centers
Global Biopharmaceuticals Contract Manufacturing Market Size by Service & CAGR (2025-2032)
Market Overview
Manufacturing
Formulation & Fill-Finish
Packaging & Labeling
Other Services
Global Biopharmaceuticals Contract Manufacturing Market Size by Type & CAGR (2025-2032)
Market Overview
Biologic Drug Substance Manufacturing
Biologic Drug Product Manufacturing
Global Biopharmaceuticals Contract Manufacturing Market Size by Scale Of Operation & CAGR (2025-2032)
Market Overview
Commercial Operations
Clinical Operations
Global Biopharmaceuticals Contract Manufacturing Market Size by Source & CAGR (2025-2032)
Market Overview
Mammalian Expression Systems
Non-Mammalian Expression Systems
Global Biopharmaceuticals Contract Manufacturing Market Size by Molecule Type & CAGR (2025-2032)
Market Overview
Monoclonal Antibodies
Cell & Gene Therapies
Antibody-Drug Conjugates
Vaccines
Therapeutic Peptides & Proteins
Other Molecule Types
Global Biopharmaceuticals Contract Manufacturing Market Size by Therapeutic Area & CAGR (2025-2032)
Market Overview
Oncology
Autoimmune Diseases
Metabolic Diseases
Cardiovascular Diseases
Neurology
Infectious Diseases
Other Therapeutic Areas
Global Biopharmaceuticals Contract Manufacturing Market Size & CAGR (2025-2032)
North America (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
US
Canada
Europe (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
Brazil
Rest of Latin America
Middle East & Africa (Service, Type, Scale Of Operation, Source, Molecule Type, Therapeutic Area)
